A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
The Lancet al Twitter: "Phase 3 trial suggests the addition of metronomic adjuvant capecitabine to chemoradiotherapy significantly improved failure-free survival in patients with high-risk locoregionally advanced nasopharyngeal carcinoma, with a ...
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure - Digestive and Liver Disease
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects - Ng - 2022 - International Journal of Cancer - Wiley Online Library
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
PDF) A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
PDF) Efficacy and Toxicity of Metronomic Capecitabine in Advanced Hepatocellular Carcinoma *
PDF) Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Oncologynews (@Oncologynewspro) / Twitter
Metronomic chemotherapy in breast cancer | Semantic Scholar
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study – topic of research paper in Clinical
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
![PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/957fa2625a87315f5d56f5911f5b8b269f747b86/6-Table2-1.png "PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar")
PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?: Trends in Cancer
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept | Scientific Reports
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial - ScienceDirect
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial - ScienceDirect
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
PDF) Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study | Rita Golfieri and Franco Trevisani - Academia.edu
PDF) Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage - Frontiers
